SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX: INO), focused on the development of genetic vaccines for infections and cancers and a novel replacement for surgery to treat cancers, announced today that the company’s president and CEO, Avtar Dhillon, MD, will present a corporate overview of Inovio at the Acumen BioFin Rodman & Renshaw 4th Annual Global Health Care Conference on Monday, May 14, 2007 at 4:40 p.m. CET (10:40 a.m. ET). The conference will be held at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco, May 14 - 15, 2007.
